Skip to content

Natural Heart Health Supplement Trial

Natural Heart Health Supplement Trial

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06671769
Enrollment
60
Registered
2024-11-04
Start date
2025-01-15
Completion date
2025-05-01
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholesterol, Cholesterol (total and HDL)

Keywords

heart health

Brief summary

We are running a 3-month trial of an experimental natural heart health supplement. Participants will take a daily dose of an experimental natural heart health supplement in powdered format, chocolate flavor. The trial will assess changes in heart biomarkers such as Total Cholesterol, HDL-C, LDL-C, Triglycerides, and High-Sensitivity C-reactive protein (hs-CRP).

Detailed description

Heart disease is a leading cause of death in the United States, and maintaining healthy cholesterol levels is crucial for heart health. While social media and the press have focused on trendier treatments for general longevity, for most of us keeping our cholesterol in check will make a major impact. Research indicates that natural substances long used in Eastern medicine, can positively affect cholesterol levels and reduce inflammation, both vital for cardiovascular wellness. This study aims to empower participants with evidence-based insights about the effectiveness of a natural heart health supplement in managing cholesterol levels and reducing inflammation. By participating, you'll contribute to valuable research while potentially enhancing your heart health through natural means. This study aims to assess the impact of a natural heart health supplement on Total Cholesterol, HDL-C, LDL-C, Triglycerides, and hs-CRP levels over three months. Our objective is to provide evidence supporting or refuting the supplement's efficacy.

Interventions

DIETARY_SUPPLEMENTHeart Health Supplement

This is a natural heart health supplement in powdered format, chocolate flavor where participants will take a daily dose.

Sponsors

Efforia, Inc
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The Natural Heart Health Supplement Trial is designed as a single-arm treatment study, where participants will serve as their own controls. This innovative approach, termed a Signal Phase study at Efforia, aims to evaluate the potential efficacy and safety of an experimental natural heart health supplement over a 3-month period. Participants will consume a daily dose of the supplement, which is administered in a chocolate-flavored powdered format. The primary objective is to assess the impact of the supplement on key heart health biomarkers, including Total Cholesterol, HDL-C, LDL-C, Triglycerides, and High-Sensitivity C-reactive protein (hs-CRP). By utilizing this methodology, the study will provide preliminary insights into the supplement's effects, offering a directional indication of potential positive results.

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Exclusion criteria

* Individuals with known soy allergies * Individuals with liver disease * Pregnant or breastfeeding individuals

Design outcomes

Primary

MeasureTime frameDescription
Total Cholesterolfrom Baseline to 30 day and 90 day.Total Cholesterol as measured by an at-home blood collection kit returned to the lab
HDL Cholesterolfrom baseline to 30 day and 90 dayas measured by an at-home blood collection kit returned to the lab
LDL CholesterolBaseline to 30 day and 90 dayas measured by an at-home blood collection kit returned to the lab
TriglyceridesFrom baseline to 30 day and 90 dayas measured by at-home blood collection returned to lab

Secondary

MeasureTime frameDescription
hs-CRPfrom baseline to 30 day and 90 dayas measured by at-home blood test returned to a lab.

Countries

United States

Contacts

Primary ContactMatthew Amsden
help@efforia.com(646) 679-2479

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026